Anaheim-based drug maker Questcor Pharmaceuticals Inc. said Wednesday that it appointed Rajesh Asarpota as its new chief financial officer. His appointment is effective Feb. 17.
Asarpota succeeds current financial chief Michael Mulroy, who will become executive vice president, strategic affairs and general counsel.
Asarpota was most recently vice president, finance at Life Technologies Corp., a Carlsbad-based biotechnology company that was recently acquired by Waltham, Mass.-based Thermo Fisher Scientific Inc.
Questcor makes H.P. Acthar Gel, an injectable drug for various conditions, including multiple sclerosis flare-ups and nephrotic syndrome, a kidney disorder.
